ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-14 |

Results: 14

Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release

Authors: Sato, Y Schmidt, AG Kiriazis, H Hoit, BD Kranias, EG

Citation: Y. Sato et al., Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release, J MOL CEL C, 33(9), 2001, pp. 1757-1759

Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure

Authors: Haghighi, K Schmidt, AG Hoit, B Brittsan, AG Yatani, A Lester, JW Zhai, J Kimura, Y Dorn, GW MacLennan, DH Kranias, EG

Citation: K. Haghighi et al., Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J BIOL CHEM, 276(26), 2001, pp. 24145-24152

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation

Authors: Sato, Y Kiriazis, H Yatani, A Schmidt, AG Hahn, H Ferguson, DG Sako, H Mitarai, S Honda, R Mesnard-Rouiller, L Frank, KF Beyermann, B Wu, GY Fujimori, K Dorn, GW Kranias, EG

Citation: Y. Sato et al., Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation, J BIOL CHEM, 276(12), 2001, pp. 9392-9399

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality

Authors: Dash, R Kadambi, VJ Schmidt, AG Tepe, NM Biniakiewicz, D Gerst, MJ Canning, AM Abraham, WT Hoit, BD Liggett, SB Lorenz, JN Dorn, GW Kranias, EG

Citation: R. Dash et al., Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, CIRCULATION, 103(6), 2001, pp. 889-896

Microemulsion formulation of cyclosporin (Sandimmun Neoral (R)) vs Sandimmun (R): Comparative safety, tolerability and efficacy in severe active rheumatoid arthritis

Authors: Yocum, DE Allard, S Cohen, SB Emery, P Flipo, RM Goobar, J Jayawardena, S Job-Deslandre, C Jubb, RW Kruger, K Vaz, AL Manger, B Mur, E Nygaard, H Weiner, SM Rainer, F Sack, MR Schiff, MH Schnitzer, TJ Trigg, LB Whatmough, I Schmidt, AG

Citation: De. Yocum et al., Microemulsion formulation of cyclosporin (Sandimmun Neoral (R)) vs Sandimmun (R): Comparative safety, tolerability and efficacy in severe active rheumatoid arthritis, RHEUMATOLOG, 39(2), 2000, pp. 156-164

Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo

Authors: Schmidt, AG Kadambi, VJ Ball, N Sato, Y Walsh, RA Kranias, EG Hoit, BD

Citation: Ag. Schmidt et al., Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo, J MOL CEL C, 32(9), 2000, pp. 1735-1744

Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo (vol 32, pg 1735, 2000)

Authors: Schmidt, AG Kadambi, VJ Ball, N Sato, Y Walsh, RA Kranias, EG Hoit, BD

The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility

Authors: Zvaritch, E Backx, PH Jirik, F Kimura, Y de Leon, S Schmidt, AG Hoit, BD Lester, JW Kranias, EG MacLennan, DH

Citation: E. Zvaritch et al., The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J BIOL CHEM, 275(20), 2000, pp. 14985-14991

Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban

Authors: Brittsan, AG Carr, AN Schmidt, AG Kranias, EG

Citation: Ag. Brittsan et al., Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban, J BIOL CHEM, 275(16), 2000, pp. 12129-12135

Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo

Authors: Zhai, J Schmidt, AG Hoit, BD Kimura, Y MacLennan, DH Kranias, EG

Citation: J. Zhai et al., Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo, J BIOL CHEM, 275(14), 2000, pp. 10538-10544

Genetic approaches to elucidate the regulatory role of phospholamban in the heart

Authors: Schmidt, AG Kranias, EG

Citation: Ag. Schmidt et Eg. Kranias, Genetic approaches to elucidate the regulatory role of phospholamban in the heart, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 39-52

Screening for basiliximab exposure-response relationships in renal allotransplantation

Authors: Kovarik, JM Moore, R Wolf, P Abendroth, D Landsberg, D Soulillou, JP Gerbeau, C Schmidt, AG

Citation: Jm. Kovarik et al., Screening for basiliximab exposure-response relationships in renal allotransplantation, CLIN TRANSP, 13(1), 1999, pp. 32-38

Body condition in blesbok x bontebok hybrids in the Oviston Nature Reserve, Eastern Cape Province

Authors: Schmidt, AG

Citation: Ag. Schmidt, Body condition in blesbok x bontebok hybrids in the Oviston Nature Reserve, Eastern Cape Province, S AFR J W R, 29(4), 1999, pp. 145-147

Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: A double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics

Authors: Anderson, IF Helve, T Hannonen, P Leirisalo-Repo, M Gilboe, IM Nissila, M Keystone, EC Kraag, GR Bjorneboe, O Chalmers, A Dovland, H Mueller, E Richard, F Whatmough, I Schmidt, AG Kovarik, JM

Citation: If. Anderson et al., Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: A double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics, J RHEUMATOL, 26(3), 1999, pp. 556-562

Risultati: 1-14 |